People & Business :: Earnings/Finance
Codexis’s loss widens in fourth quarter
10:20 AM MST | February 28, 2013 | Deepti Ramesh
Codexis (Redwood City, CA), a developer of engineered enzymes for pharmaceutical, biofuel, and chemical production, has reported a net loss of $15.5 million in the fourth quarter of 2012, compared with a net loss of $5.3 million in the year-ago quarter. Fourth-quarter sales decreased 76%, to $7.9 million, primarily because of the termination of Codexis’s collaborative research agreement with Shell as of 31 August 2012, Codexis says. Product revenue in the fourth quarter of 2012 was $6.8 million, a decrease from $15.5 million in the prior-year quarter...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee